Investigating the effect of Bifidobacterium lactis (Biokid) on tissue transglutaminase antibody based on a randomized controlled clinical trial (RCT)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250520065819N1

Enrollment

Registered

2025-06-01

Start date

2025-06-22

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac. Celiac disease

Interventions

Intervention 1: Intervention group: Probiotic recipient. Intervention 2: Control group: Not taking probiotics.

Eligibility

Sex/Gender

All

Age

2 Years to 16 Years

Inclusion criteria

Inclusion criteria: Children aged 2 to 16 years With a definitive diagnosis of celiac disease Referred to the Pediatric Gastroenterology Subspecialty Clinic of Rahimi Hospital in Khorramabad and Parental consent for children to be included in the study.

Exclusion criteria

Exclusion criteria: Drug intolerance Drug side effects Parental lack of consent for the child to participate during the study

Design outcomes

Primary

Measure	Time frame
The effect or lack of effect of probiotic consumption on TTG. Timepoint: Time of diagnosis, 3 months later, 6 months later. Method of measurement: Checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmanolah mirzaei

Khoram-Abad University of Medical Sciences

hesamodin.hoseini1994@gmail.com+98 66 3312 0172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026